In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Human metapneumovirus (hMPV) cases continue to be reported in several states across India, although the number of cases is ...

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

The human metapneumovirus ... in 2001 and is part of the Pneumoviridae family along with respiratory syncytial virus, or RSV, according to the CDC. It may have been circulating even earlier ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

To accommodate an influx of patients suffering from respiratory illnesses, Union Health has installed a portable medical tent ...

New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly ...

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...